| Target Price | $18.36 |
| Price | $12.88 |
| Potential |
42.55%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Dole 2026 .
The average Dole target price is $18.36.
This is
42.55%
register free of charge
$22.58
75.27%
register free of charge
$14.14
9.78%
register free of charge
|
|
| A rating was issued by 11 analysts: 8 Analysts recommend Dole to buy, 2 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Dole stock has an average upside potential 2026 of
42.55%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 8.48 | 9.04 |
| 2.79% | 6.69% | |
| EBITDA Margin | 4.04% | 4.44% |
| 2.69% | 9.88% | |
| Net Margin | 1.48% | 1.38% |
| 1.58% | 6.81% |
7 Analysts have issued a sales forecast Dole 2025 . The average Dole sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an Dole EBITDA forecast 2025. The average Dole EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Dole Analysts have issued a net profit forecast 2025. The average Dole net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 1.31 | 1.32 |
| 0.77% | 0.76% | |
| P/E | 9.93 | |
| EV/Sales | 0.22 |
7 Analysts have issued a Dole forecast for earnings per share. The average Dole EPS is
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


